mevion

Mevion Medical Systems is set to install its MEVION S250 proton therapy system at the MedStar Georgetown University Hospital, north-west Washington, Columbia, US, to treat adult and paediatric cancer patients.

MedStar has secured final approval to start construction of the proton therapy centre at its Lombardi Comprehensive Cancer Center.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The MEVION S250 device delivers precise, non-invasive treatment advantages and capabilities with a significantly reduced footprint, improved reliability, more efficient patient access, and dramatically lower implementation and operational costs.

Proton therapy is an advanced form of external radiation treatment for different cancers in sensitive areas such as central nervous system, chest, head and neck, eye and prostate.

MedStar intends to begin the construction of the centre this autumn, while the system installation is expected to be complete in 2016.

"Proton therapy is an advanced form of external radiation treatment for different cancers in sensitive areas such as central nervous system, chest, head and neck, eye and prostate."

MedStar Georgetown University Hospital president Richard Goldberg said: "The addition of proton therapy to our experienced and internationally known cancer programme is a natural progression for us as the only provider in the region with a long history of serving both children as well as adults with cancer.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

"We are excited to bring this important technology to our community and to give our patients yet another cutting-edge cancer treatment option."

Mevion Medical Systems president and CEO Joseph Jachinow said: "The MEVION S250 proton therapy system provides a significant benefit to cancer patients while redefining the economics and accessibility of proton therapy."

The company has also installed the system at the Kling Proton Therapy Center at Barnes-Jewish Hospital in Washington University of St Louis, Missouri.

In addition, the systems are being installed at Robert Wood Johnson University Hospital in New Jersey, Stephenson Cancer Center at the University of Oklahoma, First Coast Oncology in Florida, University of Florida Health Cancer Center at Orlando Health and University Hospitals Seidman Cancer Center in Ohio.

Image: The MEVION S250 provides the benefits of proton therapy without the size, complexity and cost of traditional proton therapy treatments. Photo: courtesy of Business Wire.